(Press-News.org) European Society of Endocrinology and Endocrine Society publish Joint Guideline on Glucocorticoid-induced Adrenal Insufficiency (GC-AI)
As focal points for endocrinology and hormone research, both the European Society of Endocrinology (ESE) and the Endocrine Society (ES) regularly produce clinical guidelines with recommendations for patient care, either in collaboration with other Societies or independently. Guideline development at each society is overseen by a Clinical Committee, and all guidelines are subject to a rigorous review process before being published. This is undertaken by society members and relevant parties, such as patient advocacy groups.
Where it is considered beneficial, patient support literature is prepared alongside the guidelines to provide patients with assistance in understanding and managing their condition.
This Joint Guideline is designed to help clinicians manage patients who have, or are at risk of developing, glucocorticoid-induced adrenal insufficiency (GC-AI). At least 1% of the global population uses chronic glucocorticoid therapy as anti-inflammatory or immune-suppressive agents.
The Guideline, titled ‘Diagnosis and therapy of glucocorticoid-induced adrenal insufficiency’, will appear in the May 2024 issues of the societies respective journals, the European Journal of Endocrinology and The Journal of Clinical Endocrinology & Metabolism. Patient-facing materials on glucocorticoid-induced adrenal insufficiency are also in development and will be made available via the ESE Patient Zone in May 2024.
This is the first Guideline developed and published jointly by ESE and ES. The societies are planning to publish a new Joint Guideline each year to maximise outreach as well as to cover potential differences in clinical practice between Europe and the United States of America.
The working group behind this Joint Guideline was led by co-chairs Professor Felix Beuschlein (ESE) and Dr Tobias Else (ES).
Professor Beuschlein, says:
“Our starting point was to define the clinical problem and knowledge gaps that come with glucocorticoid-induced adrenal insufficiency, for which we set out to provide some guidance – even in the absence of strong scientific evidence. We also wanted to make sure that we had good representation both from Europe and the US to cover potential differences in clinical practice. In this, we were privileged to gather an excellent team of specialists with great knowledge, diligence and enthusiasm – all of which is required to get through the process of writing a guideline from scratch.
“The discussions between the panel members during the writing of the Guideline, and the review process which included all members of both societies, has resulted in a level of consensus that has not been reached before. I hope that the global reach of this Joint Guideline goes beyond what either society could reach independently.”
Dr Else, says:
“The Endocrine Society and ESE collaborative guidelines on glucocorticoid-induced adrenal insufficiency are an important step towards a global collaboration in guideline development. Despite having differences in access to medications and other clinical resources, the evidence for diagnosing and treating a condition is the same.
“I believe the future will bring us closer to true global guidelines, which integrate the global diversity in culture and medical practices and can be adapted locally in accordance with resources. The work on the combined guidelines brought a tremendous learning experience for me personally, and hopefully they will be a useful resource for medical providers worldwide!”
In 2025, the societies will publish a Joint Guideline on Diabetes in Pregnancy; in 2026, a Joint Guideline on Arginine Vasopressin Resistance (AVP-R) and Arginine Vasopressin Deficiency (AVP-D); and in 2027, a Joint Guideline on Male Hypogonadism.
Funding for the development of Joint Guidelines is provided by the Societies, no other entity provides financial or other support.
Images
Images can be downloaded here.
Password: GC-AIGuideline
******** ENDS ********
About the European Society of Endocrinology
The European Society of Endocrinology (ESE) provides a platform to develop and share leading research and best knowledge in endocrine science and medicine. By uniting and representing every part of the endocrine community, we are best placed to improve the lives of patients. With over 5,000 individual members and through the 48 National Societies involved with the ESE Council of Affiliated Societies (ECAS) ESE represents a community of over 20,000 European endocrinologists. We inform policy makers on health decisions at the highest level through advocacy efforts across Europe. The European Journal of Endocrinology is ESE’s flagship with a current Impact Factor of 5.8, five-year Impact Factor: 6.3. The journal (published by Oxford University Press) publishes high-quality original clinical and translational research papers and reviews in adult and paediatric endocrinology, as well as international clinical practice guidelines and position statements. Website: https://academic.oup.com/ejendo/
To find out more about ESE, please visit www.ese-hormones.org. Follow us on Twitter @ESEndocrinology, Facebook @EuropeanSocietyofEndocrinology and LinkedIn: linkedin.com/company/european-society-of-endocrinology.
About Professor Felix Beuschlein
Felix Beuschlein is Professor of Internal Medicine/Endocrinology and Director of the Clinic for Endocrinology, Diabetology and Clinical Nutrition at the University Hospital Zurich in Switzerland. He received his medical degree from the School of Medicine at the University of Würzburg and completed his medical training in Freiburg, both in Germany. For postdoctoral studies he joined the University of Michigan in Ann Arbor. Following a professorship for Endocrine Research at the University of Munich, since 2017 he has acted as director and chair at the University of Zurich. In November 2023, he received the ‘Transatlantic Alliance Award’, a joint award from the European Society of Endocrinology and the Endocrine Society which recognises an international leader who has made significant advancements in endocrine research on both sides of the Atlantic - in Europe and the United States.
About Endocrine Society
Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.
The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.
About Dr. Tobias Else
Tobias Else, MD, is an Associate Professor of Internal Medicine at the University of Michigan in the United States. He received his MD from the University of Hamburg, Germany and completed a residency in internal medicine and fellowship in endocrinology at the University of Michigan. His focus is adrenal diseases and inherited syndromes that lead to the development of endocrine tumors. Dr. Else is currently serving on the Endocrine Society's Endocrine Board Review faculty writing group.
END
European Society of Endocrinology and Endocrine Society publish Joint Guideline on glucocorticoid-induced adrenal insufficiency (GC-AI)
2024-05-13
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Endocrine Society and European Society of Endocrinology publish joint guideline on glucocorticoid-induced adrenal insufficiency
2024-05-13
WASHINGTON—The joint guideline is designed to help clinicians manage patients who have, or are at risk of developing, glucocorticoid-induced adrenal insufficiency. At least 1% of the global population uses chronic glucocorticoid therapy as anti-inflammatory or immune-suppressive agents.
The guideline, titled “Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency,” will appear in the May 2024 issues of the Societies’ respective journals, The Journal of Clinical Endocrinology & Metabolism and the European Journal of Endocrinology. ...
Some varieties of annual flowers have a place in pollinator-friendly gardens
2024-05-13
Annapolis, MD; May 13, 2024—While wildflowers and perennials are a must for supporting pollinators, there's no denying the popularity of many annual flowers for their colorful, visual appeal. Annuals are often thought of as pollinator "deserts," but a new study suggests choosing the right varieties can give annual flowers a role in nourishing bees and other pollinating insects in home gardens.
In a two-year study, researchers at Michigan State University observed pollinators visiting 25 different varieties, or cultivars, of the six most popular annual ...
Plant virus treatment shows promise in fighting metastatic cancers in mice
2024-05-13
An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego.
The treatment, composed of nanoparticles fashioned from the cowpea mosaic virus—a virus that infects black-eyed pea plants—showed remarkable success in improving survival rates and suppressing the growth of metastatic tumors across various cancer models, including colon, ovarian, melanoma and breast cancer. Similar outcomes were also observed when the treatment was administered to mice whose tumors were surgically removed.
The findings were published recently in Advanced Science.
The ...
SwRI studies boiling processes in partial gravity aboard parabolic flights
2024-05-13
SAN ANTONIO — May 13, 2024 —Southwest Research Institute is studying the process of boiling liquids under partial gravity conditions in a series of parabolic flights. The internally funded project, conducted in collaboration with Texas A&M University, aims to better understand how liquids boil on different surfaces in partial gravity. Boiling liquids will likely be required during future extended space missions to the Moon or Mars to support surface power, life support systems, cryogenic fuel production and in situ resource utilization.
“We ...
Prostate cancer study: More health benefits from plant-based diet
2024-05-13
Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco.
A study of more than 2,000 men with localized prostate cancer found that eating a primarily plant-based diet was associated with a 47% lower risk that their cancer would progress, compared with those who consumed the most animal products.
This amounted to eating just one or two more servings per day of healthy foods, particularly vegetables, fruits, and whole grains, while eating fewer animal products, like dairy and meat. The study followed ...
When consumers would prefer a chatbot over a person
2024-05-13
COLUMBUS, Ohio – Actually, sometimes consumers don’t want to talk to a real person when they’re shopping online, a new study suggests.
In fact, what they really want is a chatbot that makes it clear that it is not human at all.
In a new study, researchers at The Ohio State University found that people preferred interacting with chatbots when they felt embarrassed about what they were buying online – items like antidiarrheal medicine or, for some people, skin care products.
“In general, research shows people would rather interact with a human customer ...
Intense ultrasound extracts genetic info for less invasive cancer biopsies #ASA186
2024-05-13
OTTAWA, Ontario, May 13, 2024 – Ultrasound imaging offers a valuable and noninvasive way to find and monitor cancerous tumors. However, much of the most crucial information about a cancer, such as specific cell types and mutations, cannot be learned from imaging and requires invasive and damaging biopsies. One research group developed a way to employ ultrasound to extract this genetic information in a gentler way.
At the University of Alberta, a team led by Roger Zemp explored how intense ultrasound can release biological indicators of disease, or biomarkers, from cells. These biomarkers, ...
Weight loss drug linked with reduced need for diuretics in heart failure patients
2024-05-13
Lisbon, Portugal – 13 May 2024: Semaglutide reduces the need for loop diuretic use and dose, and has positive effects on symptoms, physical limitations, and body weight in patients with heart failure with preserved ejection fraction (HFpEF) regardless of diuretic use, according to late breaking research presented today at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).1
HFpEF is a condition in which the heart pumps normally but is too stiff to fill properly, rendering the heart unable to support the body’s need for oxygen-rich blood. The condition is becoming more common as populations ...
Getting out of the political echo chamber
2024-05-13
Civilized political debates may seem increasingly out of reach as democracies across the world face rising polarization, but people still want to discuss issues with people they disagree with – especially those who present themselves as balanced and willing to seek solutions that work for everyone or open to learning new information, according to two studies published by the American Psychological Association.
One study, published in the Journal of Experimental Psychology: General, examined how U.S. politicians and ordinary Americans with opposing political beliefs could share their ideas on divisive issues in a way that improved respect regardless of political ...
Alarming rise of electronic vaping use in U.S. adolescents
2024-05-13
Electronic vapor products (EVPs), also known as e-cigarettes or vaping devices, have an allure because of their marketed image as a safer alternative to traditional cigarette smoking and for their variety of appealing flavors.
Yet, they contain many substances beyond nicotine, including propylene glycol, glycerin, flavorings and potentially harmful chemicals such as formaldehyde and metals, which could pose significant health risks such as respiratory disease, cardiovascular disease and cancer. Vaping also is strongly linked with a serious medical condition that damages the lungs due to the vitamin E acetate, an additive used ...